FDA probing serious adverse events linked to Ariad's cancer drug

(Reuters) - The U.S. Food and Drug Administration said it is investigating an increasing number of reports of serious and life-threatening adverse events in patients taking Ariad Pharmaceuticals Inc's leukemia drug, Iclusig. Ariad's shares fell 7 percent in early trade on Friday. In a safety notice posted on its website, the regulator advised patients taking Iclusig to seek immediate medical attention if they experience symptoms suggesting a heart attack. The notice comes after Ariad disclosed on Wednesday that the FDA asked the company to stop enrolling patients in clinical trials of Iclusig. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/fda-probing-serious-adverse-events-linked-ariads-cancer-145043042--finance.html